CALL/AMGEN/450/0.1/16.08.24 | Market Closed - BOERSE MUENCHEN 19:26:50 10/06/2024 BST | ||
| 0.019 EUR | -9.52% |
|
| Current month | -5.00% | ||
| 1 month | -62.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 10/06/24 | 0.019 | -9.52% |
| 07/06/24 | 0.021 | -25.00% |
| 06/06/24 | 0.028 | -20.00% |
| 05/06/24 | 0.035 | 0.00% |
| 04/06/24 | 0.035 | -16.67% |
Real-time BOERSE MUENCHEN
Last update June 10, 2024 at 07:26 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GG4ZF8 |
| ISIN | DE000GG4ZF82 |
| Date issued | 07/03/2024 |
| Strike | 450 $ |
| Maturity | 16/08/2024 (67 Days) |
| Parity | 10 : 1 |
| Emission price | 0.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.073 € |
|---|---|
| Lowest since issue | 0.011 € |
| Spread | 0.07 € |
| Spread % | 83.33% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
304.7
USD
Average target price
316.3
USD
Spread / Average Target
+3.79%
- Stock Market
- Warrants
- Warrant
